Track the 동국제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 동국제약 has published 21 insider filings. The latest transaction was reported on 26 May 2026 (Sale). Among the most active insiders: 브이아이피자산운용. Every trade is accessible without an account.
21
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
14 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.